0B68 Knudsen, Karen E. - Thomas Jefferson University - Thomas Jefferson University
kxk016

Karen E. Knudsen, PhD

Contact Dr. Knudsen

Kimmel Cancer Center
233 S. Tenth Street, Suite 1008
Philadelphia, PA 19107

(215) 503-8574

Most Recent Peer-reviewed Publications

  1. Novel actions of next-generation taxanes benefit advanced stages of prostate cancer
  2. Consequence of the tumor-associated conversion to cyclin D1b
  3. Models of neuroendocrine prostate cancer
  4. Hormone whodunit: Clues for solving the case of intratumor androgen production
  5. The retinoblastoma tumor suppressor modulates DNA repair and radioresponsiveness
  6. Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapy
  7. PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer
  8. Transcriptional roles of PARP1 in cancer
  9. Commentary : Fusing transcriptomics to progressive prostate cancer
  10. Beyond DNA repair: DNA-PK function in cancer
  11. AR function in promoting metastatic prostate cancer
  12. Progesterone receptor-cyclin D1 complexes induce cell cycle-dependent transcriptional programs in breast cancer cells
  13. Targeting PARP-1 allosteric regulation offers therapeutic potential against cancer
  14. AMPed up to treat prostate cancer: Novel AMPK activators emerge for cancer therapy
  15. USP22 regulates oncogenic signaling pathways to drive lethal cancer progression
  16. Targeting cell cycle and hormone receptor pathways in cancer
  17. A hormone-DNA repair circuit governs the response to genotoxic insult
  18. Targeted radiosensitization of ETS fusion-positive prostate cancer through PARP1 inhibition
  19. IGF2 revs the steroidogenesis engine
  20. The epigenetic modifier ubiquitin-specific protease 22 (USP22) regulates embryonic stem cell differentiation via transcriptional repression of sex-determining region Y-box 2 (SOX2)
0